Table 2 Patients outcome during and after VV-ECMO support for more than 50 days

Disease course

 Second high dose steroid treatment

4 (29)

 ECMO circuits or oxygenator changes

4 (±3)

 Length of MV (days)

103 (±34)

 Time from start ECMO to Vt improvement (days)

53 (±25)

 Time from start ECMO to FDO₂ decrease (days)

64 (±29)

 Time from start decrease FDO₂ to weaning ECMO (days)

34 (±18)

 ECMO duration (days)

87 (±29)

 ICU length-of-stay (days)

109 (±38)

Complications

 Bacterial pneumonia

14 (100%)

 Ischemic stroke

1 (7%)

 Cerebral bleeding

1 (7%)

 Acalculous cholecystitis

1 (7%)

 Renal failure

6 (43%)

 Pneumothorax

3 (21%)

 Pleural effusions

14 (100%)

 Hemothorax

1 (7%)

 Septic shock

8 (56%)

 Right ventricular failure

3 (21%)

Outcomes

 90-day survival

12 (86%)

 Weaned from ECMO

11 (79%)

 Discharge from hospital

10 (71%)

 1-year survival

10 (71%)